Kronos Bio Stock (NASDAQ: KRON) stock price, news, charts, stock research, profile.
Open | $1.34 |
Close | $1.32 |
Volume / Avg. | 60.92K / 444.21K |
Day Range | 1.30 - 1.38 |
52 Wk Range | 0.69 - 2.09 |
Market Cap | $78.20M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 1.71% |
Days to Cover | 3.75 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kronos Bio (NASDAQ:KRON) through any online brokerage.
Other companies in Kronos Bio’s space includes: Serina Therapeutics (AMEX:SER), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), T2 Biosystems (NASDAQ:TTOO) and Eagle Pharmaceuticals (NASDAQ:EGRX).
There is no analysis for Kronos Bio.
Kronos Bio has a consensus price target of $8.56.
The stock price for Kronos Bio (NASDAQ: KRON) is $1.3013 last updated July 26, 2024 at 5:37 PM EDT.
There are no upcoming dividends for Kronos Bio.
Kronos Bio’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Kronos Bio.
Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.